These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6097531)

  • 21. Apoptotic response of uveal melanoma cells upon treatment with chelidonine, sanguinarine and chelerythrine.
    Kemény-Beke A; Aradi J; Damjanovich J; Beck Z; Facskó A; Berta A; Bodnár A
    Cancer Lett; 2006 Jun; 237(1):67-75. PubMed ID: 16019128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ionic strength and pH on the binding of sanguinarine to deoxyribonucleic acid.
    Nandi R; Chaudhuri K; Maiti M
    Photochem Photobiol; 1985 Nov; 42(5):497-503. PubMed ID: 4089033
    [No Abstract]   [Full Text] [Related]  

  • 23. Protective effect of bioantioxidants on argemone oil/sanguinarine alkaloid induced genotoxicity in mice.
    Ansari KM; Dhawan A; Khanna SK; Das M
    Cancer Lett; 2006 Nov; 244(1):109-18. PubMed ID: 16458423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of alkaloid sanguinarine and a pharmaceutical preparation ukrain on modulation of vesicular membrane fusion and actin cytoskeleton of macrophages].
    Mozhenok TP; Beliaeva TN; Leont'eva EA; Faddeeva MD
    Tsitologiia; 2005; 47(10):860-5. PubMed ID: 16711384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effect of sanguinarine, chelerythrine and chelidonine on DNA damage and cell viability in primary mouse spleen cells and mouse leukemic cells.
    Kaminskyy V; Lin KW; Filyak Y; Stoika R
    Cell Biol Int; 2008 Feb; 32(2):271-7. PubMed ID: 18029203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo DNA damaging potential of sanguinarine alkaloid, isolated from argemone oil, using alkaline Comet assay in mice.
    Ansari KM; Dhawan A; Khanna SK; Das M
    Food Chem Toxicol; 2005 Jan; 43(1):147-53. PubMed ID: 15582207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sanguinarine as an antiplaque agent: a review of current literature.
    Sarbin AG; Koertge Te; Nuckols PF
    Va Dent J; 1987; 64(2):8-12. PubMed ID: 3300080
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of the limited analyte solubility on its mobility and zone shape: electrophoretic behavior of sanguinarine and chelerythrine around pH 7.
    Vespalec R; Vlcková M; Kubán V
    Electrophoresis; 2005 Sep; 26(17):3265-72. PubMed ID: 16143979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine: biological activities and dental care applications.
    Walterová D; Ulrichová J; Válka I; Vicar J; Vavrecková C; Táborská E; Harjrader RJ; Meyer DL; Cerná H; Simánek V
    Acta Univ Palacki Olomuc Fac Med; 1995; 139():7-16. PubMed ID: 8686560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of cytochrome P450 1A in sanguinarine detoxication.
    Vrba J; Kosina P; Ulrichová J; Modrianský M
    Toxicol Lett; 2004 Jul; 151(2):375-87. PubMed ID: 15183462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma.
    De Stefano I; Raspaglio G; Zannoni GF; Travaglia D; Prisco MG; Mosca M; Ferlini C; Scambia G; Gallo D
    Biochem Pharmacol; 2009 Dec; 78(11):1374-81. PubMed ID: 19643088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Concentration of four alkaloids in the aerial parts of Eomecon chionantha from different mounth in year].
    Du F; Wang S; Xie Z
    Zhong Yao Cai; 2000 Apr; 23(4):189-90. PubMed ID: 12575122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sanguinarine--a new antiplaque agent.
    Southard GL; Boulware RT; Walborn DR; Groznik WJ; Senior SL; Yankell SL
    Compend Contin Educ Dent (Lawrenceville); 1984; Suppl 5():S72-5. PubMed ID: 6590188
    [No Abstract]   [Full Text] [Related]  

  • 34. Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells.
    Weerasinghe P; Hallock S; Tang SC; Trump B; Liepins A
    Exp Toxicol Pathol; 2006 Aug; 58(1):21-30. PubMed ID: 16735106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine.
    Malíková J; Zdarilová A; Hlobilková A; Ulrichová J
    Cell Biol Toxicol; 2006 Nov; 22(6):439-53. PubMed ID: 16964588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of 3-methylcholanthrene pretreatment on sanguinarine toxicity in mice.
    Williams MK; Dalvi S; Dalvi RR
    Vet Hum Toxicol; 2000 Aug; 42(4):196-8. PubMed ID: 10928680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of sanguinarine on ventricular refractoriness.
    Whittle JA; Bissett JK; Straub KD; Doherty JE; McConnell JR
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):377-80. PubMed ID: 7414056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conventional protein kinase C isoenzymes undergo dephosphorylation in neutrophil-like HL-60 cells treated by chelerythrine or sanguinarine.
    Vrba J; Dvorák Z; Ulrichová J; Modrianský M
    Cell Biol Toxicol; 2008 Jan; 24(1):39-53. PubMed ID: 17610032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of sanguinarine on the GABA synthesizing enzyme glutamate decarboxylase in vitro.
    Netopilova M; Drsata J; Ulrichová J
    Pharmazie; 1996 Aug; 51(8):589-91. PubMed ID: 8794470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins.
    Ahsan H; Reagan-Shaw S; Breur J; Ahmad N
    Cancer Lett; 2007 May; 249(2):198-208. PubMed ID: 17005319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.